Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Siltuximab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Siltuximab 100mg powder for solution for infusion vials
0802040AMAAABAB
|
Siltuximab | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Siltuximab 400mg powder for solution for infusion vials
0802040AMAAAAAA
|
Siltuximab | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Sylvant 100mg pdr for concentrate for inf vials
0802040AMBBABAB
|
Sylvant | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Sylvant 400mg pdr for concentrate for inf vials
0802040AMBBAAAA
|
Sylvant | Siltuximab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.